XJXi-Juan Jiang

Xi-Juan Jiang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xi-Juan Jiang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Bo-Han Li

    The First Clinical Medical College, Nanjing University of Chinese Medicine, 155 Hanzhong Road, Qinhuai District, 210000, Nanjing, PR China

    1 shared publication
  • Chang-Yu Liu

    School of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Jinghai District, 301600, Tianjin, China

    1 shared publication
  • Jia-Yan Wang

    College Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Jinghai District, 301600, Tianjin, China

    1 shared publication
  • Jie Wang

    School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Jinghai District, 301600, Tianjin, China

    1 shared publication
  • Maojuan Guo

    School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China

    1 shared publication
  • Qian-He Wang

    School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Jinghai District, 301600, Tianjin, China

    1 shared publication

Latest Publications

  • Piezo1 in heart failure: A new perspective from cytomechanical sensing to diverse cellular pathways

    by Jia-Yan Wang, Bo-Han Li, Chang-Yu Liu, Qian-He Wang, Jie Wang, Mao-Juan Guo, Xi-Juan Jiang

    Piezo1, a mechanosensitive cation channel characterized by its distinctive transmembrane trimeric structure, plays a pivotal role in mediating cellular responses to mechanical stimuli. It facilitates calcium influx, and recent studies highlight its involvement in heart failure (HF) pathophysiology, where its dysregulation significantly contributes to disease progression. Specifically, Piezo1 upregulation impacts diverse cellular processes across cardiovascular cell types, including cardiomyocytes, fibroblasts, endothelial cells (ECs), and vascular smooth muscle cells (VSMCs). Unlike previous studies that have focused predominantly on isolated signaling pathways, this review offers a comprehensive examination of Piezo1's mechanosensory functions across diverse cardiovascular cell populations. We explored how Piezo1 modulates key pathological processes in heart failure, including calcium homeostasis, reactive oxygen species (ROS) production, fibrosis, vascular remodeling, and immune activation. Furthermore, we investigated how Piezo1-mediated interactions between different cell types, such as cardiomyocyte-fibroblast crosstalk and endothelial-smooth muscle cell interactions, serve as critical drivers of disease progression. Additionally, we discuss the therapeutic potential of targeting Piezo1, suggesting that modulating its activity may offer a novel strategy to mitigate the pathological effects of heart failure. By providing new insights into the multifaceted roles of Piezo1, this review highlights the potential of mechanosensitive ion channels as therapeutic targets for cardiovascular disease.